What's the outlook for the Telstra (ASX:TLS) share price?

The Telstra share price is on watch for FY22.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Telstra Corporation Ltd (ASX: TLS) share price is up 4% at the time of writing after delivering its FY21 result to the market.

Telstra said that on a reported basis, total income decreased by 11.6% to $23.1 billion and net profit grew 3.4% to $1.9 billion.

On a guidance basis, underlying earnings before interest, tax, depreciation and amortisation (EBITDA) fell 9.7% to $6.7 billion. That included an in-year NBN headwind of around $650 million and an estimated $380 million financial impact from COVID-19. Excluding the in-year NBN headwind, underlying EBITDA in FY21 dropped $70 million.

But FY22 has already started and it has provided guidance. The guidance can have an impact on the Telstra share price.

map of australia with golden 5G sitting on it representing telstra share price profit result

Image source: Getty Images

What is Telstra expecting in FY22?

Telstra said that its guidance shows the underlying business returning to full year growth.

Total income is expected to be in a range of $21.6 billion to $23.6 billion in the new financial year.

Underlying EBITDA is expected to be in a range of $7 billion to $7.3 billion (compared to $6.7 billion in FY21).

The telco is expecting to spend $2.8 billion to $3 billion on capital expenditure. Free cashflow after lease payments is expected to be between $3.5 billion to $3.9 billion.

One of the key ways that Telstra is looking to help its profit and the Telstra share price is its T22 strategy.

Asset sales were part of the plan, with Telstra monetising its InfraCo Towers business by selling a 49% stake. It's returning half of the net proceeds with a $1.35 billion to shareholders with a share buyback.

Under the T22 strategy, it is driving productivity. Total operating expenses dropped 10.2% in FY21. Underlying fixed costs declined $490 million, or 8.1%, during FY21. Since FY16, the company has achieved around $2.3 billion of net productivity and remains on track to meet its target of $2.7 billion by the end of FY22.

The company has reduced its number of roles by 8,300 net full time roles, meeting the T22 commitment one year early and also reducing 17,400 indirect roles and removing on average more than four management layers.

Telstra's focus

The company has a number of initiatives that could help the Telstra share price and profit.

In an interview with the Australian Financial Review, the Telstra CEO Andrew Penn said:

I'd say three things – one is that it's absolutely front and centre about continuing to transform customer experience and just taking that to the next level.

Secondly, it's about growth, both within the core but also some of our new business investments are really starting to help to get some traction.

Obviously, we're going to be launching energy, sort of imminently. And then it's also about building on all of the capabilities and the foundations that we've laid in T22.

Mr Penn also reference the telco's recent acquisition of MedicalDirector for $350 million. This business currently supports around 23,000 medical practitioners and is used to deliver more than 80 million medical consultations a year. It is a GP clinical and practice management software company.

Mr Penn also said:

What we're trying to do is we are focused on very much digitising and connecting different parts of the healthcare system.

You would appreciate the healthcare system is highly fragmented, and it isn't as efficient as it could be – it could be much more digitally enabled.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day session for the ASX.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

These shares are under pressure on hump day. But why?

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why EOS, Humm, New Hope, and Sims shares are storming higher today

These shares are having a good session on hump day. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »